-
Editorial11-15-2021
Gynecologists and Obstetricians Working Group to Face the COVID-19 Pandemic in Brazil: Successful Experience to be Followed
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(8):585-587
Abstract
EditorialGynecologists and Obstetricians Working Group to Face the COVID-19 Pandemic in Brazil: Successful Experience to be Followed
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(8):585-587
Views127In addition to causing relevant changes in the global routine, the COVID-19 pandemic status announced and recognized by the World Health Organization (WHO) on March 11, 2020, made it clear that no country was ready to face an infectious disease that spread rapidly and involved objective risk of death. The retrospective assessment of the sequence […]See more -
Editorial10-18-2021
Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(7):503-506
Abstract
EditorialChallenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(7):503-506
Views115Gestational trophoblastic neoplasia (GTN) is a rare tumor that arises from placental tissues and exhibits a high cure rate when treated with cytotoxic chemotherapy. Although its most common origin is hydatidiform mole, GTN can develop from any type of pregnancy: abortion, ectopic pregnancy, or preterm/term gestation. The early diagnosis of GTN is the key to […]See more -
Editorial07-30-2021
Placenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(5):347-350
Abstract
EditorialPlacenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(5):347-350
Views187What are the Relevant Risk Factors for Pas Screening? Numeroushistorical risk factors have been associated with the occurrence of PAS, including maternal obesity, advanced maternal age and parity, previous uterine surgery (including illegal terminations of pregnancy), and use of assisted reproductive technologies. However, there is no doubt that the concomitance of the only risk factor […]See more -
Editorial07-27-2021
The Individual Progress Test of Gynecology and Obstetrics Residents (TPI-GO): The Brazilian Experience by FEBRASGO
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):425-428
Abstract
EditorialThe Individual Progress Test of Gynecology and Obstetrics Residents (TPI-GO): The Brazilian Experience by FEBRASGO
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(6):425-428
Views139Individual Feedback to Candidates Feedback on the results of each candidate’s performance in the IPT-GO is provided confidentially through a password-protected online system with personal access. The aim of this measure is to avoid embarrassment, discrimination or disqualification of candidates with unsatisfactory performance. Therefore, this evaluation is not intended to rank candidates or services. The […]See more -
Editorial06-18-2021
Provision and Guidance for Postpartum Contraception – Ensuring Reproductive Rights during Times of Crises
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):247-249
Abstract
EditorialProvision and Guidance for Postpartum Contraception – Ensuring Reproductive Rights during Times of Crises
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(4):247-249
Views148Reproductive choice and access to contraception are basic rights for all women, representing a major step forward in the improvement of gender equality. Sexual and reproductive health is paramount when considering public health, and has been directly affected by the COVID-19 pandemic, since these services suffered a reduction in their capacity for elective care, including […]See more -
Editorial05-24-2021
Shortcomings in the training program of medical residency during the COVID-19 pandemic in Brazil. How will they be repaired?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):155-157
Abstract
EditorialShortcomings in the training program of medical residency during the COVID-19 pandemic in Brazil. How will they be repaired?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(3):155-157
Views141Medical Residency Programs (MRPs) have been presented as the dominant model for postgraduate medical training worldwide. They are considered the gold standard by the medical community and give different status to doctors who hold these titles. The success of this model resides in the link established between theoretical learning and the practice experienced in health […]See more -
Editorial03-29-2021
We have Vaccine for COVID-19! What to Recommend for Pregnant Women?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(2):81-83
Abstract
EditorialWe have Vaccine for COVID-19! What to Recommend for Pregnant Women?
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(2):81-83
Views147On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced by the Chinese company Sinovac and in Brazil, will be produced by the Butantã Institute (São Paulo). The second is an adenovirus non-replicating viral […]See more -
Editorial03-08-2021
Call to Eliminate Cervical Cancer in the Next Decade with a Focus on Brazil
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(1):1-2
Abstract
EditorialCall to Eliminate Cervical Cancer in the Next Decade with a Focus on Brazil
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(1):1-2
Views244At the 73rd General Assembly, in 2020, the World Health Organization (WHO) approved the adoption of the “Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem,” based on the guarantee of the three following pillars: 1) that 90% of girls up to 15 years of age receive the vaccine against […]See more